Clinical Trial Update: Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing gabapentin with lorazepam for alcohol withdrawal has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcohol Withdrawal

Drugs mentioned

• Gabapentin (Gabapentin)
• Lorazepam (Lorazepam)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcoholism | Phase 2 | Status: COMPLETED